Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 1, 1999, Pages

  Busico, Kristina M ^a,b,c,d   Marshall, Katherine L ^a,b,c   Ksiazek, Thomas G ^a,b,c   Roels, Thierry H ^a,b,c   Fleerackers, Yon ^a,b,c   Feldmann, Heinz ^a,b,c   Khan, Ali S ^a,b,c   Peters, C J ^a,b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; CHILD; CONFERENCE PAPER; CONGO; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RURAL AREA; SEROPREVALENCE; URBAN AREA; VIRUS HEMORRHAGIC FEVER;

EID: 0032999827     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514309     Document Type: Conference Paper

References (14)

1. 1. Khan AS, Tshioko FK, Heymann DL, et. al. The reemergence of Ebola hemorrhagic fever. Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(suppl 1):S76-86.
2. 2. Bource P, Bergmann JF. Ebola virus infection in man: a serologic and epidemiological survey in the Camaroons. Am J Trop Med Hyg 1983; 32:1465-6.
3. 3. Blackburn NK, Searle L, Taylor P. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren. Trans R Soc Trop Med Hyg 1982;72:803-5.
4. 4. Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis 1980;142:372-6.
5. 5. Johnson ED, Gonzalez JP, Georges A. Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. Trans R Soc Trop Med Hyg 1993;87:530-5.
6. 6. Ivanoff B, Duquesnoy P, Languillat G, et al. Hemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué, Trans R Soc Trop Med Hyg 1982;76:719-20.
7. 7. Gonzalez JP, Josse R, Johnson ED, et al. Antibody prevalence against haemorrhagic fever viruses in randomized representative central African populations. Res Virol 1989;140:319-31.
8. 8. Johnson ED, Gonzalez JP, Georges A. Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. Trans R Soc Trop Med Hyg 1993;87:536-8.
9. 9. Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg 1988;38:407-10.
10. 10. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999;179(suppl 1):S192-8..
11. 11. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. New York: Van Nostrand Reinhold, 1982.
12. 12. Centers for Disease Control and Prevention. Update: filovirus infection in animal handlers. Morb Mortal Wkly Rep 1990;39:221.
13. 13. Centers for Disease Control and Prevention. Update: filovirus infections among persons with occupational exposure to nonhuman primates. Morb Mortal Wkly Rep 1990;39:266-7, 273.
14. 14. Feldmann H, Nichol ST, Klenk HD, Peters CJ, Sanchez A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 1994;199:469-73.